- Home
- / AUSTAR Group
AUSTAR Group
Stock Price
$0.7
2024-08-20
Market Capitalization
$358.8 M
2024-08-20
Revenue
¥1.8 B
FY, 2023
AUSTAR Group Summary
Company Summary
- Overview
- AUSTAR Group (also known AUSTAR Lifesciences) is a technology-based pharmaceutical engineering solution provider. It offers clean utility equipment and systems, freeze-drying technologies, sterile filling and visual inspection equipment, pharmaceutical process contamination control products, single-use bioprocess equipment and consumables, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1991
- HQ
- CN | view all locations
- Website
- https://www.austar.com.hk
- Cybersecurity rating
Table of Contents
AUSTAR Group Financials
Summary Financials
- Revenue (FY, 2023)
- ¥1.8B
- Gross profit (FY, 2023)
- ¥343.7M
- Net income (FY, 2023)
- (¥107.5M)
- Cash (FY, 2023)
- ¥163.8M
- EBIT (FY, 2023)
- (¥68.1M)
- Enterprise value
- $681.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2024